Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson bought 207 shares of the stock in a transaction dated Tuesday, February 11th. The stock was purchased at an average price of GBX 73 ($0.92) per share, with a total value of £151.11 ($190.20).
Giles Wilson also recently made the following trade(s):
- On Monday, January 13th, Giles Wilson bought 222 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 68 ($0.86) per share, with a total value of £150.96 ($190.01).
Dr. Martens Trading Down 0.0 %
DOCS stock opened at GBX 72 ($0.91) on Friday. The company has a market capitalization of £698.90 million, a PE ratio of 10.21, a P/E/G ratio of 6.40 and a beta of 0.11. Dr. Martens plc has a 12 month low of GBX 49.32 ($0.62) and a 12 month high of GBX 100 ($1.26). The firm’s 50-day moving average is GBX 72.34 and its 200 day moving average is GBX 65.63. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.
Dr. Martens Cuts Dividend
The business also recently declared a dividend, which will be paid on Tuesday, April 8th. Investors of record on Thursday, March 6th will be paid a GBX 0.85 ($0.01) dividend. This represents a yield of 1.47%. The ex-dividend date is Thursday, March 6th. Dr. Martens’s dividend payout ratio is presently 42.53%.
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Recommended Stories
- Five stocks we like better than Dr. Martens
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Using the MarketBeat Stock Split Calculator
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- What is the S&P 500 and How It is Distinct from Other Indexes
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.